Switch to ADA Accessible Theme
Close Menu
Florida Whistleblower & Qui Tam Lawyer
Schedule Your Free Confidential Consultation
+

Monthly Archives: September 2022

Litigation3

Multi-Million Dollar Whistleblower Award Issued In Health Care Billing Fraud False Claims Act Case

By Guttman, Freidin & Celler |

On July 20th, 2022, the United States Attorneys’ Office for the District of Massachusetts announced that Inform Diagnostics—a Texas based medical industry company that previously operated Miraca Life Sciences—has agreed to pay $16 million as part of a health care billing fraud case. The False Claims Act settlement includes a nearly $2.75 million whistleblower… Read More »

Facebook Twitter LinkedIn
Whistleblower3

Major False Claims Act Settlement: Pharmaceutical Company Will Pay $900 Million

By Guttman, Freidin & Celler |

According to a report from Reuters, Biogen—the American multinational pharmaceutical giant with headquarters in Cambridge, Massachusetts—has reached an agreement in principle to pay approximately $900 million to resolve a False Claims Act lawsuit. The preliminary settlement was reached days before the trial was set to begin. The pharmaceutical company was accused of paying illegal… Read More »

Facebook Twitter LinkedIn
HealthcareBus

Long-Term Care Company Pays More Than $5.5 Million In Whistleblower-Initiated False Claims Act Case

By Guttman, Freidin & Celler |

On August 10th, 2022, the United States Attorneys’ Office for the Southern District of Indiana announced that American Senior Communities, L.L.C (ASC)—a long-term care company with a main headquarters in Indianapolis, IN—will pay more than $5.5 million to resolve a False Claims Act lawsuit. The case involves allegations of Medicare billing fraud. Here, our… Read More »

Facebook Twitter LinkedIn
GavelScales

DOJ Says Supreme Court Should Not Review False Claims Act Dispute

By Guttman, Freidin & Celler |

According to a report from Reuters, the Department of Justice (DOJ) is saying that the Supreme Court of the United States should not review a False Claims Act dispute. The DOJ contends that there is no sufficiently large circuit split for the nation’s top court to get involved in the matter. Here, our whistleblower… Read More »

Facebook Twitter LinkedIn